Guanfacine Hydrochloride Extended Release (Intuniv XR) Tablets: For the Treatment of Attention-Deficit/Hyperactivity Disorder
Book. 2015 07
Authors:
Abstract
The objective of this review was to compare the clinical benefits and harms of guanfacine extended release (GXR; brand name: Intuniv XR) with those of other active treatments and placebo in children aged six to 12 years with attention-deficit/hyperactivity disorder (ADHD).
PMID: 26962601
via http://www.ncbi.nlm.nih.gov/pubmed/26962601?dopt=Abstract